|
30 Mar 2019 |
AstraZeneca and Daiichi Sankyo enter collaboration for novel HER2-targeting antibody-drug conjugate
|
|
30 Mar 2019 |
Boehringer Ingelheim Enhances Oncology R&D with Novel MacroDel Delivery Technology Via Acquisition of ICD Therapeutics
|
|
28 Mar 2019 |
Lilly and ImmuNext Announce Licensing and Research Collaboration
|
|
26 Mar 2019 |
Ichor Medical Systems Announces Collaboration and Research License Agreement with AstraZeneca to Develop DNA-based Monoclonal Antibody Platform
|
|
22 Mar 2019 |
LegoChem Biosciences and Takeda Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates in Immuno-Oncology
|
|
21 Mar 2019 |
Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody® Molecule
|
|
20 Mar 2019 |
Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
|
|
20 Mar 2019 |
Domainex and SpiroChem Enter a Fragment Drug Discovery Partnership
|
|
20 Mar 2019 |
Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases
|
|
19 Mar 2019 |
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
|
|
19 Mar 2019 |
Ono Pharmaceutical and twoXAR Announce Drug Discovery Research Collaboration
|
|
14 Mar 2019 |
Merck KGaA, Darmstadt, Germany, Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology
|
|
13 Mar 2019 |
Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca
|
|
13 Mar 2019 |
Flow Pharma, Inc. and OncoImmunity AS partner for the Development of FlowVaxTM Personalized Cancer Vaccines
|
|
13 Mar 2019 |
HitGen and SPARC Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration
|
|
11 Mar 2019 |
Parkinson’s disease: Servier and Oncodesign join forces to investigate new line of research
|
|
11 Mar 2019 |
Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology Pipeline
|
|
11 Mar 2019 |
Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program
|
|
11 Mar 2019 |
aTyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring
|
|
11 Mar 2019 |
Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel Sphingosine 1-Phosphate (S1P) Receptor Modulator
|
|
09 Mar 2019 |
TaiwanJ Pharmaceuticals Obtained US$26M Deal for Licensing and Co-Development Contract with Newsoara Biopharma on JKB-122 Asian Rights
|
|
09 Mar 2019 |
Xencor Announces Closing of Research Collaboration and License Agreement with Genentech
|
|
06 Mar 2019 |
ReForm Biologics Announces Collaboration Agreement with Astellas Pharma Inc.
|
|
06 Mar 2019 |
AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes
|
|
06 Mar 2019 |
Glenmark Pharmaceuticals Announces Appointment of Alessandro Riva as CEO of its New Innovation Company
|
